Division of Neuroscience and Behavior (DNB)
The Division of Neuroscience and Behavior (DNB) promotes research on ways in which neuronal and behavioral systems are influenced by genetic, developmental, and environmental factors in conjunction with alcohol exposure to engender alcohol use disorder.
Featured Funding Opportunities
Below are some of our current funding opportunity announcements. Before submitting your application, please reach out to the staff member listed under “Scientific/Research Contacts” of the announcement to learn more.
-
Open Date:
Expiration Date:
-
Open Date:
Expiration Date:
Frequently Asked Questions
Does your research proposal align with the NIAAA mission?
Answer: We advise you to contact a Program Director listed either below or on a particular Funding Opportunity Announcement (FOA) to discuss your research interests before preparing your application. This will not only help determine whether your proposal is of interest to NIAAA, but will aid in the preparation of your grant application.
Who should I contact within the Division about my research proposal?
Answer: Below is a list of Program Directors and their areas of research interests. The best way to contact a Program Director whose interest aligns with your own is via email. Alternatively, if you would like to speak by phone, please indicate this in an email and a Program Director will contact you soon thereafter.
What is the process for applying for funding?
Answer: When submitting a grant application to NIAAA, extramural researchers can find instructions in the Funding Opportunity Announcement to which they are applying. See the NIAAA application process homepage for information about grant applications, the peer review process, and understanding how applications are selected for funding.
Our Staff
| Name | Position | Focus Area* |
|---|---|---|
| Antonio B. Noronha, Ph.D. |
Director
|
Director, Division Neuroscience & Behavior
|
| Mark D. Egli, Ph.D. |
Deputy Division Director
|
Behavioral Neuroscience; Deputy Division Director; Pain; Preclinical Medication Development
|
| Mohammed Akbar, Ph.D. |
Program Officer
|
GPCR Signaling; Metabolism and Stress; Neurodegeneration; Neuroendocrinology; Neuronal Signaling
|
| Hemin Chin, Ph.D. |
Program Officer
|
Animal Genetic Models; Human Genetics
|
| Changhai Cui, Ph.D. |
Program Officer
|
Molecular neuroscience; Neurocircuits; Neuroimmune Interactions; Neuromodulation; Neurotechnology; Signaling transduction
|
| Ivana Grakalic, Ph.D. |
Program Officer
|
Aggression; Behavioral Control; Comorbidity and Polysubstance Use; Learning & Memory
|
| Qi-Ying Liu, MD, M.S. |
Program Officer
|
Cellular Neurobiology & Neurocircuitry; Neuroadaptation; Neuromodulation; Synaptic Plasticity
|
| Dominique Lorang-Leins, Ph.D. |
Program Officer
|
Animal Genetic Models; Genomics and Epigenetics; Molecular Neurobiology and Genetics
|
| John A. Matochik, Ph.D. |
Program Officer
|
Cognitive and Affective Neuroscience; Computational Neuroscience; FAS/FASD; Neuroimaging
|
| Abbas Parsian, Ph.D. |
Program Officer
|
G x E; Genetic Networks; Human Genetics & Genomics; Next Generation Sequencing
|
| Elizabeth Powell, Ph.D. |
Program Officer
|
Developmental Neurobiology; Fetal Alcohol Spectrum Disorder (FASD)
|
| Soundar Regunathan, Ph.D. |
Program Officer
|
Brain Injury; Neurogenesis and Neurodevelopment; Neurotoxicology; Pain
|
| Benjamin Xu. Ph.D. |
Program Officer
|
Cognitive Neuroscience; Functional Neuroimaging
|